Patent classifications
A23V2250/21368
Methods and materials for reducing multiple risk factors associated with the metabolic syndrome
Provided are processes of reducing and/or eliminating risk factors associated with metabolic syndrome in a subject through the administration of a nelumbo extract. The nelumbo extract supplement is administered orally, intravenously, or subcutaneously. In one aspect, a daily dose of 10-1,000 mg of the extract supplement is administered to the subject for a period of 6 weeks to 6 months.
Methods and materials for reducing multiple risk factors associated with the metabolic syndrome
Provided are processes of reducing and/or eliminating risk factors associated with metabolic syndrome in a subject through the administration of a nelumbo extract. The nelumbo extract supplement is administered orally, intravenously, or subcutaneously. In one aspect, a daily dose of 10-1,000 mg of the extract supplement is administered to the subject for a period of 6 weeks to 6 months.
Gel capsule containing sterol and solubilising agent
The present invention relates to gel capsules comprising sterol and solubilizer for use as food supplement or as pharmaceutical.
GEL CAPSULE CONTAINING STEROL AND SOLUBILISING AGENT
The present invention relates to gel capsules comprising sterol and solubilizer for use as food supplement or as pharmaceutical.